Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer.
Connect Tissue Res
; 49(3): 265-9, 2008.
Article
em En
| MEDLINE
| ID: mdl-18661357
ABSTRACT
A novel tissue-specific shRNA delivery system has been developed using cre-lox technology. Conditionally silenced pSico vector containing oligonucleotides of CD44shRNA and tissue-specific promoter-driven Cre-recombinase expression vector are packaged into transferrin-coated nanoparticles that can deliver shRNA into specific tumors. This system has strong potential in cancer therapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Terapia Genética
/
Receptores de Hialuronatos
/
RNA Interferente Pequeno
/
Interferência de RNA
/
Ácido Hialurônico
/
Neoplasias
Limite:
Animals
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Connect Tissue Res
Ano de publicação:
2008
Tipo de documento:
Article
País de afiliação:
Estados Unidos